Latest Articles
B.C. opens applications for IVF funding, offering up to $19K per patient - My East Kootenay Now
B.C. opens applications for IVF funding, offering up to $19K per patient My East Kootenay Now
Published: July 3, 2025, 3:52 a.m.
Certain type of hormone therapy increases breast cancer risk, study finds - CBS News
Certain type of hormone therapy increases breast cancer risk, study finds CBS News
Published: July 3, 2025, 12:59 a.m.
Is Asia ready for a workplace revolution in reproductive health? - HRM Asia
Is Asia ready for a workplace revolution in reproductive health? HRM Asia
Published: July 3, 2025, 12:32 a.m.
Minilaparoscopic Versus Conventional Laparoscopic Hysterectomy: Insights from a Single-Center Retrospective Cohort Study with Legal Considerations.
Background and Objectives: We compared mini-laparoscopic and laparoscopic hysterectomy in terms of surgery duration, postoperative pain, conversion rate, blood loss, postoperative complications (Clavien-Dindo classification), and the length of hospital stay. …
Published: July 3, 2025, midnight
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test - MedCity News
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test MedCity News
Published: July 2, 2025, 8:17 p.m.
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications - TipRanks
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications TipRanks
Published: July 2, 2025, 5:03 p.m.
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis - Frontiers
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis Frontiers
Published: July 2, 2025, 4:08 p.m.
Organon's non-hormonal endometriosis hope dashed - FirstWord Pharma
Organon's non-hormonal endometriosis hope dashed FirstWord Pharma
Published: July 2, 2025, 3:25 p.m.
Organon stops work on drug once viewed as ‘game-changing’; NextPoint culls an asset - Endpoints News
Organon stops work on drug once viewed as ‘game-changing’; NextPoint culls an asset Endpoints News
Published: July 2, 2025, 2:34 p.m.
Link copied to clipboard!